methotrexate has been researched along with Cachexia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Castillo-Martinez, L; Hinojosa-Azaola, A; Llorente, L; Lozada-Mellado, M; Ogata-Medel, M; Pineda-Juarez, JA; Rocha-Gonzalez, HI | 1 |
| Chatterjee, M; Chatterjee, U; Chattopadhyay, S; De, S; Kundu, S | 1 |
| Garssen, J; Hartog, A; Hulsman, J | 1 |
| BELDOTTI, L; SCHWARTZ, RS | 1 |
| Chester, KR; Lemmey, AB; Maddison, PJ; Marcora, SM; Mittal, G | 1 |
| Brennan, MF; Maher, M; Sloan, GM | 1 |
| Baracos, VE; Cynober, L; Gugins, S; Le Bricon, T | 1 |
| Jehn, U; Kohlschütter, B | 1 |
| Andersson, BS; Dreizen, S; Keating, MJ; McCredie, KB | 1 |
2 trial(s) available for methotrexate and Cachexia
| Article | Year |
|---|---|
Cachexia measured by bioelectrical impedance vector analysis and risk of infection in women with rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Body Composition; Cachexia; Electric Impedance; Female; Humans; Methotrexate | 2023 |
Randomized phase 2 trial of anti-tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis.
Topics: Adipose Tissue; Antirheumatic Agents; Arthritis, Rheumatoid; Body Composition; Cachexia; Etanercept; Female; Humans; Immunoglobulin G; Immunologic Factors; Insulin-Like Growth Factor I; Male; Methotrexate; Middle Aged; Muscle, Skeletal; Receptors, Tumor Necrosis Factor; Treatment Outcome; Tumor Necrosis Factor-alpha; Weight Gain | 2006 |
7 other study(ies) available for methotrexate and Cachexia
| Article | Year |
|---|---|
Allylpyrocatechol attenuates methotrexate-induced hepatotoxicity in a collagen-induced model of arthritis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Antirheumatic Agents; Arthritis, Experimental; Cachexia; Catechols; Chemical and Drug Induced Liver Injury; Collagen Type II; Drug Synergism; Edema; Female; Gene Expression Regulation; Interleukin-6; Lipopolysaccharides; Liver; Male; Methotrexate; Oxidative Stress; Rats; Rats, Sprague-Dawley; Splenomegaly; Tumor Necrosis Factor-alpha | 2018 |
Locomotion and muscle mass measures in a murine model of collagen-induced arthritis.
Topics: Animals; Antirheumatic Agents; Arthritis, Experimental; Body Weight; Cachexia; Disability Evaluation; Disease Models, Animal; Disease Progression; Gait Disorders, Neurologic; Image Processing, Computer-Assisted; Locomotion; Male; Methotrexate; Mice; Mice, Inbred DBA; Muscle, Skeletal; Muscular Atrophy; Severity of Illness Index; Treatment Outcome; Video Recording | 2009 |
THE TREATMENT OF CHRONIC MURINE HOMOLOGOUS DISEASE: A COMPARATIVE STUDY OF FOUR "IMMUNOSUPPRESSIVE" AGENTS.
Topics: Animals; Antigens; Cachexia; Graft vs Host Disease; Immunosuppressive Agents; Mercaptopurine; Methotrexate; Mice; Pharmacology; Prednisone; Radiation Effects; Research; Spleen; Transplantation Immunology | 1965 |
Nutritional effects of surgery, radiation therapy, and adjuvant chemotherapy for soft tissue sarcomas.
Topics: Adolescent; Adult; Blood Proteins; Body Weight; Cachexia; Cyclophosphamide; Doxorubicin; Female; Humans; Leukocyte Count; Lymphocytes; Male; Methotrexate; Middle Aged; Sarcoma; Serum Albumin; Soft Tissue Neoplasms | 1981 |
Negative impact of cancer chemotherapy on protein metabolism in healthy and tumor-bearing rats.
Topics: Animals; Antineoplastic Agents; Cachexia; Cisplatin; Cyclophosphamide; DNA; Eating; Female; Fluorouracil; Intestine, Small; Liver; Liver Neoplasms, Experimental; Methotrexate; Muscle, Skeletal; Nitrogen; Organ Size; Proteins; Rats; Rats, Sprague-Dawley; RNA; Weight Loss | 1995 |
[Parenteral feeding during aggressive chemotherapy of various neoplasms].
Topics: Adult; Bleomycin; Body Weight; Cachexia; Cyclophosphamide; Fluorouracil; Humans; Methotrexate; Middle Aged; Neoplasms; Parenteral Nutrition; Vincristine | 1978 |
Nutritional deficiencies in patients receiving cancer chemotherapy.
Topics: Antineoplastic Agents; Cachexia; Folic Acid Deficiency; Humans; Hypoproteinemia; Methotrexate; Neoplasms; Niacin; Nutrition Disorders; Nutritional Status; Pellagra; Riboflavin Deficiency; Thymine; Vitamin B Deficiency; Vitamin K Deficiency | 1990 |